MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
04 04 2019
Historique:
received: 16 10 2018
accepted: 14 02 2019
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 1 7 2020
Statut: epublish

Résumé

The possible association between the membrane-associated guanylate kinase with inverted domain structure-1 (MAGI1) and inflammation has been suggested, but the molecular mechanisms underlying this link, especially during atherogenesis, remain unclear. In endothelial cells (ECs) exposed to disturbed flow (d-flow), p90 ribosomal S6 kinase (p90RSK) bound to MAGI1, causing MAGI1-S741 phosphorylation and sentrin/SUMO-specific protease 2 T368 phosphorylation-mediated MAGI1-K931 deSUMOylation. MAGI1-S741 phosphorylation upregulated EC activation via activating Rap1. MAGI1-K931 deSUMOylation induced both nuclear translocation of p90RSK-MAGI1 and ATF-6-MAGI1 complexes, which accelerated EC activation and apoptosis, respectively. Microarray screening revealed key roles for MAGI1 in the endoplasmic reticulum (ER) stress response. In this context, MAGI1 associated with activating transcription factor 6 (ATF-6). MAGI1 expression was upregulated in ECs and macrophages found in atherosclerotic-prone regions of mouse aortas as well as in the colonic epithelia and ECs of patients with inflammatory bowel disease. Further, reduced MAGI1 expression in Magi1-/+ mice inhibited d-flow-induced atherogenesis. In sum, EC activation and ER stress-mediated apoptosis are regulated in concert by two different types of MAGI1 posttranslational modifications, elucidating attractive drug targets for chronic inflammatory disease, particularly atherosclerosis.

Identifiants

pubmed: 30944250
pii: 125570
doi: 10.1172/jci.insight.125570
pmc: PMC6483653
doi:
pii:

Substances chimiques

Activating Transcription Factor 6 0
Adaptor Proteins, Signal Transducing 0
Atf6 protein, mouse 0
Cell Adhesion Molecules 0
Ribosomal Protein S6 Kinases, 90-kDa EC 2.7.11.1
Guanylate Kinases EC 2.7.4.8
MAGI1 protein, human EC 2.7.4.8
Magi1 protein, mouse EC 2.7.4.8
Cysteine Endopeptidases EC 3.4.22.-
Senp2 protein, mouse EC 3.4.22.68

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : DP2 HL123229
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117976
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133254
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130193
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134740
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL144805
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118462
Pays : United States

Références

Proteomics. 2009 Jun;9(12):3409-3412
pubmed: 29658196
Cell Stress Chaperones. 2012 Mar;17(2):275-9
pubmed: 22038282
Peptides. 2013 Oct;48:21-6
pubmed: 23927843
Metabolism. 2016 May;65(5):623-633
pubmed: 27085771
Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1;311(3):G365-76
pubmed: 27445342
Circulation. 2013 Jan 29;127(4):486-99
pubmed: 23243209
J Clin Invest. 2014 Jul;124(7):3187-99
pubmed: 24865430
J Cell Biol. 2000 Mar 6;148(5):849-56
pubmed: 10704436
Ann Rheum Dis. 2015 Oct;74(10):1875-81
pubmed: 25990289
Front Cardiovasc Med. 2018 Apr 05;5:26
pubmed: 29675417
Mol Cell Endocrinol. 1999 May 25;151(1-2):65-77
pubmed: 10411321
Circ J. 2011;75(12):2722-30
pubmed: 22076424
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15006-11
pubmed: 16217014
Nat Med. 2011 Sep 04;17(10):1225-7
pubmed: 21892181
FASEB J. 2009 Mar;23(3):916-28
pubmed: 19017743
J Biol Chem. 2001 Mar 16;276(11):7927-31
pubmed: 11118448
Biostat Bioinforma Biomath. 2013 Aug;3(3):71-85
pubmed: 25558171
Anticancer Res. 2014 Jul;34(7):3251-6
pubmed: 24982328
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5889-92
pubmed: 8392180
Circ Res. 2013 Mar 15;112(6):911-23
pubmed: 23381569
J Cell Biol. 2011 May 30;193(5):867-84
pubmed: 21624955
Mol Cell Biol. 2003 Jun;23(12):4267-82
pubmed: 12773569
Antioxid Redox Signal. 2016 Sep 1;25(7):435-50
pubmed: 26714841
Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1535-43
pubmed: 19684185
Mol Cell Biochem. 2013 Jan;372(1-2):267-73
pubmed: 23054191
Exp Cell Res. 2002 May 1;275(2):155-70
pubmed: 11969287
Mol Cell Proteomics. 2008 Sep;7(9):1598-608
pubmed: 18463090
Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2185-91
pubmed: 14576075
Gastroenterology. 2009 Jul;137(1):15-7
pubmed: 19450592
J Cell Sci. 2006 Dec 1;119(Pt 23):4952-63
pubmed: 17105770
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
JAMA Psychiatry. 2015 Jul;72(7):642-50
pubmed: 25993607
Circ Res. 2009 Aug 28;105(5):453-61
pubmed: 19661457
Mol Biol Cell. 2006 Feb;17(2):966-76
pubmed: 16339077
J Clin Invest. 2015 Mar 2;125(3):1299-310
pubmed: 25689261
Mol Cell Biol. 2006 Jun;26(12):4675-89
pubmed: 16738331
J Biol Chem. 2006 Apr 14;281(15):10243-9
pubmed: 16481319
Gastroenterology. 2015 Apr;148(4):794-805
pubmed: 25557950
J Biol Chem. 2000 Jan 21;275(3):1739-48
pubmed: 10636870
J Toxicol Sci. 2006 May;31(2):149-56
pubmed: 16772704
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8326-31
pubmed: 19416856
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Arterioscler Thromb Vasc Biol. 1998 May;18(5):677-85
pubmed: 9598824
Nat Rev Immunol. 2008 Sep;8(9):663-74
pubmed: 18670423
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2378-86
pubmed: 25301843
Cell Mol Life Sci. 2017 May;74(10):1835-1858
pubmed: 28039525
Clin Cancer Res. 2009 Apr 15;15(8):2583-7
pubmed: 19351775

Auteurs

Jun-Ichi Abe (JI)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Kyung Ae Ko (KA)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Sivareddy Kotla (S)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Yin Wang (Y)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jesus Paez-Mayorga (J)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo Leon, Mexico.

Ik Jae Shin (IJ)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Masaki Imanishi (M)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Hang Thi Vu (HT)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Yunting Tao (Y)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Miguel M Leiva-Juarez (MM)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Tamlyn N Thomas (TN)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jan L Medina (JL)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jong Hak Won (JH)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Yuka Fujii (Y)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Carolyn J Giancursio (CJ)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Elena McBeath (E)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Ji-Hyun Shin (JH)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Liliana Guzman (L)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Rei J Abe (RJ)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Jack Taunton (J)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.

Naoki Mochizuki (N)

Department of Cell Biology, National Cardiovascular Center Research Institute, Osaka, Japan.

William Faubion (W)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

John P Cooke (JP)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Keigi Fujiwara (K)

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Scott E Evans (SE)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Nhat-Tu Le (NT)

Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH